Abstract Background: Clinical trials for rare epilepsies face substantial methodological and ethical challenges. Small and heterogeneous populations, coupled with limited…
Abstract Background: An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and…
Abstract Microfluidic technology is applied across various research areas including organ-on-chip (OOC) systems. The main material used for microfluidics is…
Abstract Objective: Rett syndrome (RTT), commonly caused by methyl‐CpG‐binding protein 2 (MECP2) pathogenic variants, has many comorbidities. Fifty to ninety…
Abstract There is international interest for consensus advice for prescribers working in the field of drug resistant epilepsy intending to…
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…
Abstract Introduction: Chronic cannabis use is associated with neuroanatomical alterations in the hippocampus. While adverse impacts of cannabis use are…
Abstract Introduction: Chronic cannabis use has been associated with impaired cognition and elevated psychological symptoms, particularly psychotic-like experiences. While Δ9-tetrahydrocannabinol…
Abstract Background: In many health settings, administration of medicinal cannabis poses significant implementation barriers including drug storage and safety for…